Description

OMNIPAQUE VIAL is a specialized diagnostic tool designed to enhance the clarity of imaging procedures. Manufactured by GE HealthCare, this product contains iohexol, a non-ionic, iodinated contrast medium, making it highly effective for use in X-ray and CT imaging. Its versatility allows for various administration routes, including intrathecal, intravascular, oral, and more, depending on the specific diagnostic needs.

Key Features

• Sterile and Ready-to-Use: Available as a clear, colorless to pale yellow solution, OMNIPAQUE VIAL is provided in a range of concentrations and vial sizes to suit different diagnostic requirements.
• Wide Range of Applications: Suitable for adults and children, it is indicated for procedures such as angiography, excretory urography, myelography, arthrography, and many others.
• Single-Use Vials: Ensures safety and efficacy by discarding any unused portion after administration.

Dosage and Administration

The dosage and concentration of OMNIPAQUE VIAL are tailored to the type of procedure, patient age, weight, and clinical factors. Healthcare professionals are advised to use the lowest effective dose and ensure the solution is warmed to body temperature before use to reduce viscosity. Proper hydration before and after administration is recommended to optimize results and minimize risks.

Packaging

OMNIPAQUE VIAL is available in various concentrations, ranging from 140 mg I/mL to 350 mg I/mL, and in multiple packaging options, including glass vials and polypropylene ampoules. Volume options extend from 10 mL to 500 mL, providing flexibility for different clinical settings.

Inactive Ingredients

The formulation includes trometamol, sodium calcium edetate, water for injection, and pH-adjusting agents such as hydrochloric acid and sodium hydroxide. These components ensure the solution's stability and compatibility.

Storage Instructions

• Store below 30°C and protect from light.
• Do not freeze.
• May be warmed to 37°C before use.

Safety and Precautions

OMNIPAQUE VIAL is contraindicated in individuals with hypersensitivity to iohexol or its excipients, and in specific medical conditions such as thyrotoxicosis and anuria. It is crucial to monitor patients for adverse reactions, particularly those with pre-existing health conditions like renal impairment or cardiovascular disease.

Potential Adverse Effects

While generally well-tolerated, some patients may experience mild effects such as warmth during injection or nausea. Serious reactions, though rare, can include hypersensitivity, acute kidney injury, or cardiovascular events. Adequate monitoring and hydration are essential to mitigate these risks.

Special Considerations

For pregnant or lactating individuals, and in pediatric or geriatric populations, careful consideration of the benefits and risks is necessary. OMNIPAQUE VIAL crosses the placenta and is excreted in breast milk, though typically in small amounts.

By providing enhanced imaging clarity, OMNIPAQUE VIAL supports healthcare professionals in making accurate diagnoses, ultimately contributing to improved patient care outcomes.